NASDAQ · GNOM

Global X Genomics & Biotechnology ETF financials

$70.30+0.14%

Close Sep 28, 2026 · split-adjusted

Global X Genomics & Biotechnology ETF has no quarterly financial statements on file. Funds and some foreign issuers do not file them.

Sources: Massive / Polygon daily aggregates (split-adjusted) · SEC filings via Massive · FINRA settlements via Massive · Financial Modeling Prep. Figures are dated where shown; research is informational, not investment advice. Methodology